Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

Fig. 6

EREG function analysis. A PDL1 expression of EREG-KD and EREG-NC in the U87 and U251 cell lines. B FDX1 expression of EREG-KD and EREG-NC in the U87 and U251 cell lines. C Colony formation assays were performed on U87 and U251 cell lines. D Invasion ability assays were performed on U87 and U251 cell lines by transwell. E Migration ability assays were performed on U87 and U251 cell lines by transwell.*P < 0.05, **P < 0.01, ***P < 0.001. Error bars indicate the mean ± SD

Back to article page